Inventor · disambiguated record
Lars Bode
Also filed as: BODE LARS
8 granted patents·12 pending applications·18 citations·filing 2003–2024
81Inventor score
Files withUNIV CALIFORNIA13THYSSENKRUPP STEEL EUROPE AG4BODE LARS1LOS ANGELES CHILDRENS HOSPITAL1NUTRICIA NV1
Top patents by PatentIndex Score
20 records- 0178US9290530B2Chemoenzymatic synthesis of heparin and heparan sulfate analogsUNIV CALIFORNIA·Filed 2014·Granted Mar 22, 2016·3 cites·4 claims
- 0276US11234992B2Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharidesUNIV CALIFORNIA·Filed 2019·Granted Feb 1, 2022·2 cites·5 claims
- 0374US9675649B2Disialyllacto-N-tetraose (DSLNT) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel diseaseBODE LARS·Filed 2012·Granted Jun 13, 2017·6 cites·5 claims
- 0474US2023181609A1Immunomodulatory oligosaccharidesUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0573US10160986B2Chemoenzymatic synthesis of heparin and heparan sulfate analogsUNIV CALIFORNIA·Filed 2016·Granted Dec 25, 2018·1 cites·18 claims
- 0671US2023149433A1Immunomodulatory oligosaccharidesUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0771US2023201228A1Immunomodulatory oligosaccharidesUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0865US7851450B2Gangliosides with a modified acyl functionNUTRICIA NV·Filed 2003·Granted Dec 14, 2010·5 cites·22 claims
- 0965US2021236527A1Immunomodulatory oligosaccharidesUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1065US2021236526A1Immunomodulatory oligosaccharidesUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 1162US2025000885A1Composition comprising two or more oligosaccharidesLOS ANGELES CHILDRENS HOSPITAL·Filed 2024·Application pending·0 cites
- 1261US10987718B2Method for production of a supporting member and a ladder frame or box frameTHYSSENKRUPP STEEL EUROPE AG·Filed 2019·Granted Apr 27, 2021·1 cites·18 claims
- 1359US2020237793A1Immunomodulatory oligosaccharidesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1459US2020230161A1Immunomodulatory oligosaccharidesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1555US2022143056A1Methods and therapies for treating atherosclerosis and/or hyperlipidemia using oligosaccharidesUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1652US2024335870A1Method for the production of sheet metal parts and device thereforTHYSSENKRUPP STEEL EUROPE AG·Filed 2022·Application pending·0 cites
- 1748US11896603B2Oligosaccharide as therapeutic agent for alcohol associated liver diseaseUNIV CALIFORNIA·Filed 2021·Granted Feb 13, 2024·0 cites·19 claims
- 1845US10315389B2Semi-finished product, method for producing a semi-finished product and use thereofTHYSSENKRUPP STEEL EUROPE AG·Filed 2015·Granted Jun 11, 2019·0 cites·20 claims
- 1937US2014079775A1Agents to treat/prevent amoebiasisUNIV CALIFORNIA·Filed 2012·Application pending·0 cites
- 2036US2018134008A1Semi-finished product and use thereofTHYSSENKRUPP STEEL EUROPE AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars Bode files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →